Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy

NCT02317393 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Non-seminomatous Germ Cell Tumors
Metastasis

Interventions

OTHER: K5-RGD PET
OTHER: FDG

Sponsor

Centre Francois Baclesse